Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients

Nutrients

Volumn 3, Issue 10, 2011, Pages 897-909

  Hummelen, Ruben ^a,b   Hemsworth, Jaimie ^b,c,g   Changalucha, John ^d   Butamanya, Nicodemus L ^e   Hekmat, Sharareh ^b,c   Habbema, J Dik F ^a   Reid, Gregor ^b,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c BRESCIA UNIVERSITY COLLEGE   (Canada)

^d Mwanza Research Centre   (Canada)

^e Sekou Toure Regional Hospital   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV; Immune system; Lactobacillus; Micronutrients; Probiotics

Indexed keywords

ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; BETA CAROTENE; CD4 ANTIGEN; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; HEMOGLOBIN; ICOSAPENTAENOIC ACID; IRON; NICOTINAMIDE; PALMITIC ACID; PROBIOTIC AGENT; PYRIDOXINE; SELENIUM; THIAMINE; TRACE ELEMENT; YOGHURT; ZINC;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FOOT PARESTHESIA; HAND PARESTHESIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INCIDENCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUTRITIONAL TOLERANCE; PARESTHESIA; PATIENT COMPLIANCE; PERMEABILITY BARRIER; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; TREATMENT OUTCOME;

LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

EID: 80055006971     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu3100897     Document Type: Article

References (41)

1. Beach, R.; Mantero-Atienza, E.; Shor-Posner, G. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992, 6, 701-708.
2. Tang, A.; Graham, N.; Saah, A. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am. J. Epidemiol. 1996, 143, 1244-1256.
3. Semba, R.D.; Graham, N.M.; Caiaffa, W.T.; Margolick, J.B.; Clement, L.; Vlahov, D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch. Intern. Med. 1993, 153, 2149-2154.
4. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Horowitz, A.; Hurley, A.; Hogan, C.; Boden, D.; Racz, P.; Markowitz, M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200, 761-770.
5. Lim, S.G.; Condez, A.; Lee, C.A.; Johnson, M.A.; Elia, C.; Poulter, L.W. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin. Exp. Immunol. 1993, 92, 448-454.
6. Brenchley, J.M.; Price, D.A.; Schacker, T.W.; Asher, T.E.; Silvestri, G.; Rao, S.; Kazzaz, Z.; Bornstein, E.; Lambotte, O.; Altmann, D.; et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12, 1365-1371.
7. Wallet, M.A.; Rodriguez, C.A.; Yin, L.; Saporta, S.; Chinratanapisit, S.; Hou, W.; Sleasman, J.W.; Goodenow, M.M. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010, 24, 1281-1290.
8. Gori, A.; Tincati, C.; Rizzardini, G.; Torti, C.; Quirino, T.; Haarman, M.; Ben Amor, K.; van Schaik, J.; Vriesema, A.; Knol, J.; et al. Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol. 2008, 46, 757-758.
9. Wolf, B.W.; Wheeler, K.B.; Ataya, D.G.; Garleb, K.A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 1998, 36, 1085-1094.
10. Kelly, P.; Todd, J.; Sianongo, S.; Mwansa, J.; Sinsungwe, H.; Katubulushi, M.; Farthing, M.J.; Feldman, R.A. Susceptibility to intestinal infection and diarrhoea in Zambian adults in relation to HIV status and CD4 count. BMC Gastroenterol. 2009, 9, 7.
11. Cassol, E.; Malfeld, S.; Mahasha, P.; van der Merwe, S.; Cassol, S.; Seebregts, C.; Alfano, M.; Poli, G.; Rossouw, T. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J. Infect. Dis. 2010, 202, 723-733.
12. Hummelen, R.; Hemsworth, J.; Reid, G. Micronutrients, N-Acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients 2010, 2, 626-651.
13. Kanter, A.S.; Spencer, D.C.; Steinberg, M.H.; Soltysik, R.; Yarnold, P.R.; Graham, N.M. Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J. Acquir. Immune Defic. Syndr. 1999, 21, 252-253.
14. Fawzi, W.W.; Msamanga, G.I.; Spiegelman, D.; Urassa, E.J.; McGrath, N.; Mwakagile, D.; Antelman, G.; Mbise, R.; Herrera, G.; Kapiga, S.; et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998, 351, 1477-1482.
15. Fawzi, W.W.; Msamanga, G.I.; Spiegelman, D.; Wei, R.; Kapiga, S.; Villamor, E.; Mwakagile, D.; Mugusi, F.; Hertzmark, E.; Essex, M.; et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N. Engl. J. Med. 2004, 351, 23-32.
16. Jiamton, S.; Pepin, J.; Suttent, R. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS 2003, 17, 2461-2469.
17. Kaiser, J.D.; Adriana, M.C.; Ondercin, J.P.; Gifford, S.L.; Pless, R.F.; Baum, M.K. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: A prospective, double-blinded, placebo-controlled trial. J. Acquir. Immune Defic. Syndr. 2006, 42, 523-528.
18. Kelly, P.; Shawa, T.; Mwanamakondo, S.; Soko, R.; Smith, G.; Barclay, G.R.; Sanderson, I.R. Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial. BMC Gastroenterol. 2010, 10, 72.
19. Fawzi, W.; Msamanga, G.; Spiegelman, D. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998, 351, 1477-1482.
20. WHO/FAO. Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria; Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report: Cordoba, Argentina, 2001.
21. Trois, L.; Cardoso, E.M.; Miura, E. Use of probiotics in HIV-infected children: a randomized double-blind controlled study. J. Trop. Pediatr. 2008, 54, 19-24.
22. Anukam, K.C.; Osazuwa, E.O.; Osadolor, H.B.; Bruce, A.W.; Reid, G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J. Clin. Gastroenterol. 2008, 42, 239-243.
23. Irvine, S.L.; Hummelen, R.; Hekmat, S.; Looman, C.W.; Habbema, J.D.; Reid, G. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J. Clin. Gastroenterol. 2010, 44, 201-205.
24. Rosenfeldt, V.; Benfeldt, E.; Valerius, N.H.; Paerregaard, A.; Michaelsen, K.F. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 2004, 145, 612-616.
25. Luyer, M.D.; Buurman, W.A.; Hadfoune, M.; Speelmans, G.; Knol, J.; Jacobs, J.A.; Dejong, C.H.; Vriesema, A.J.; Greve, J.W. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect. Immun. 2005, 73, 3686-3692.
26. Braat, H.; van den Brande, J.; van Tol, E.; Hommes, D.; Peppelenbosch, M.; van Deventer, S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 2004, 80, 1618-1625.
27. Giamarellos-Bourboulis, E.J.; Bengmark, S.; Kanellakopoulou, K.; Kotzampassi, K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J. Trauma 2009, 67, 815-821.
28. Allen, S.J.; Martinez, E.G.; Gregorio, G.V.; Dans, L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010, CD003048; doi:10.1002/14651858.CD003048.pub3.
29. Hummelen, R.; Vos, A.P.; van't Land, B.; van Norren, K.; Reid, G. Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int. Rev. Immunol. 2010, 29, 485-513.
30. UNAIDS. MDG6: six things you need to know about the AIDS response today. Available online: http://data.unaids.org/pub/Report/2010/20100917_mdg6_report_en.pdf (accessed on 1 October 2010).
31. Wenner, M. A cultured response to HIV. Nat. Med. 2009, 15, 594-597.
32. Reid, G.; Charbonneau, D.; Gonzalez, S.; Gardiner, G.; Erb, J.; Bruce, A.W. Ability of Lactobacillus GR-1 and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhimurium. Nutraceut Food 2002, 7, 168-173.
33. Baroja, M.L.; Kirjavainen, P.V.; Hekmat, S.; Reid, G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 2007, 149, 470-479.
34. Ministry of Health, United Republic of Tanzania, National Guidelines for the Clinical Management of HIV/AIDS, 2005. Available online: http://www.collections.infocollections.org/whocountry/en/d/Js6885e/15.3.1.html (accessed on 28 September 2010).
35. WHO. Diarrhoeal disease Factsheet No 330, August 2009. Available online: http://www.who.int/mediacentre/factsheets/fs330/en/index.html (accessed on 1 October 2010).
36. Hekmat, S.; Soltani, H.; Reid, G. Growth and survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in yogurt for use as a functional food. Food Sci. Emerg. Technol. 2009, 10, 293-296.
37. van't Land, B.; Benlhassan-Chahour, K.; Rizzardini, G.; Vriesema, A.; Garssen, J.; Trabattoni, D.; Bray, D.; Gori, A.; Clerici, M. A specific mixture of prebiotic oligosaccharides reduces hyper-immune activation and improves NK cell cytolytic activity in HAART-naive HIV positive adults. In Proceedings of 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, USA, 3-6 February 2008.
38. Mermin, J.; Lule, J.; Ekwaru, J.P.; Malamba, S.; Downing, R.; Ransom, R.; Kaharuza, F.; Culver, D.; Kizito, F.; Bunnell, R.; et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004, 364, 1428-1434.
39. Holmes, C.; Wood, R.; Badri, M.; Zilber, S.; Wang, B.; Maartens, G.; Zheng, H.; Lu, Z.; Freedberg, K.; Losina, E. CD4 Decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J. Acquir. Immune Defic. Syndr. 2006, 42, 464-469.
40. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements; Otten, J.J., Hellwig, J.P., Meyers, L.D., Eds.; National Academy of Sciences: Washington, DC, USA, 2006.
41. O'Brien, M.E.; Kupka, R.; Msamanga, G.I.; Saathoff, E.; Hunter, D.J.; Fawzi, W.W. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J. Acquir. Immune Defic. Syndr. 2005, 40, 219-225.sd